title: [Neoadjuvant hormone therapy with total radical prostatectomy: intermediate results].
authors.affiliation: Université Catholique de Louvain, Clinique Universitaire St-Luc, Service d'Urologie, Bruxelles.
authors.forename: B P
authors.initials: BP
authors.lastname: Hermans
authors.forename: F
authors.initials: F
authors.lastname: Lorge
authors.forename: F X
authors.initials: FX
authors.lastname: Wese
authors.forename: R J
authors.initials: RJ
authors.lastname: Opsomer
authors.forename: P J
authors.initials: PJ
authors.lastname: Van Cangh
mesh_terms: D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000601:surgery*; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D005485:Flutamide; D017430:Prostate-Specific Antigen
vernacular_title: Hormonothérapie néoadjuvante à la prostatectomie radicale totale: résultats à moyen terme.